Complete information for patient identifier: multiple= (b)(6).All available patient information was included, no additional patient information was available.During an investigation, it was noted that the potential exists for the assay quality control requirement to be bypassed for the first use of an alinity s hbsag confirmatory reagent kit, (ln 06p03).This event can occur if the qc run includes the alinity s hbsag reagent kit (ln 06p02), the qc run is already in progress, a newly introduced alinity s hbsag confirmatory reagent kit is loaded onto the reagent carousel, and the alinity s hbsag screening assay calibration status has transitioned to qc in process.This issue has the potential to occur when operating with the alinity s system software versions 2.8.0 and prior.A product correction letter fa 28apr2022 has been distributed to the customers to notify them of the issue and provide the immediate necessary actions to follow until the mandatory upgrade of alinity s system software version 2.8.1 can be installed.Abbott is released alinity s system software version 2.8.1 (ln 04u76-16) to correct the issue.
|
The customer reported that alinity s hbsag confirmatory assay results were generated for seven (7) sample ids without valid assay controls on (b)(6) 2023.This incident occurred on the alinity s system, serial number (b)(4) with software version 2.8.0.The customer provided the following results.Sid (b)(6): c1= 1.81 s/co (c1=> or =0.70 s/co and neutralization > or =50%=confirmed positive); c2=0.30 s/co (< 1.00 s/co=nonreactive)/neutralizing confirmatory= 92.31%.Sid (b)(6): c1=3.81 s/co ; c2=0.34 s/co ; neutralizing confirmatory=95.59%.Sid (b)(6): c1=1.33 s/co ; c2=0.38 s/co ; neutralizing confirmatory=81.84 %.Sid (b)(6): c1=1.08 s/co ; c2=0.37 s/co ; neutralizing confirmatory=78.93 %.Sid (b)(6): c1=1.56 s/co ; c2=1.67 s/co; neutralizing confirmatory=7.47 % (not confirmed).Sid (b)(6): c1=1866.26 s/co; c2= 0.48 s/co; neutralizing confirmatory= 99.98 %.Sid (b)(6): c1=1.82 s/co ; c2= 0.30 s/co; neutralizing confirmatory= 92.38%.No discrepant patient results were generated, and there was no reported impact to patient management.
|